Bo Yang
Impact in
- Geriatrics and Gerontology top 2%
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Oncology 55
- Cancer Immunotherapy and Biomarkers 13
- Lung Cancer Research Studies 8
- Co-authors
- Feng Cao (7 shared papers)Shunchang Jiao (14 shared papers)Georgette D. Kanmogne (2 shared papers)Yi Hu (16 shared papers)Yabin Wang (6 shared papers)Ruili Yu (13 shared papers)Anathbandhu Chaudhuri (1 shared paper)Yuri Persidsky (1 shared paper)
- Journals
- Frontiers in Oncology (6 papers)PLoS ONE (4 papers)Tumor Biology (4 papers)Heart (4 papers)Cancer Medicine (3 papers)
- Partner nations
- ChinaUnited StatesPhilippines
In The Last Decade
Bo Yang
211 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 148
- Geriatrics and Gerontology 109
- Cancer Research 452
- Immunology 621
- Oncology 689
- Molecular Biology 988
Countries citing papers authored by Bo Yang
This map shows the geographic impact of Bo Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Yang more than expected).
Fields of papers citing papers by Bo Yang
This network shows the impact of papers produced by Bo Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Yang. The network helps show where Bo Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 222 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 178 | |
| 2 | 2011 | 151 | |
| 3 | 2007 | 130 | |
| 4 | 2015 | 98 | |
| 5 | 2018 | 83 | |
| 6 | 2016 | 65 | |
| 7 | 2014 | 62 | |
| 8 | 2017 | 58 | |
| 9 | 2017 | 56 | |
| 10 | 2020 | 55 | |
| 11 | Long non-coding RNA NEAT1 acts as oncogene in NSCLC by regulating the Wnt signaling pathway. | 2017 | 55 |
| 12 | 2013 | 52 | |
| 13 | 2010 | 51 | |
| 14 | 2009 | 47 | |
| 15 | 2015 | 46 | |
| 16 | 2013 | 45 | |
| 17 | 2011 | 44 | |
| 18 | 2012 | 43 | |
| 19 | 2010 | 42 | |
| 20 | 2012 | 39 |
About Bo Yang
Bo Yang is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Surgery, having authored 222 papers that have together received 3.5k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (14 papers), Cancer Immunotherapy and Biomarkers (13 papers), Immunotherapy and Immune Responses (8 papers), Lung Cancer Research Studies (8 papers), Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (6 papers), Lung Cancer Treatments and Mutations (6 papers) and T-cell and B-cell Immunology (6 papers). The work is most often cited by research in Geriatrics and Gerontology (109 citations), Cancer Research (452 citations), Immunology (621 citations), Oncology (689 citations) and Molecular Biology (988 citations). Bo Yang has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Feng Cao, Shunchang Jiao, Georgette D. Kanmogne, Yi Hu, Yabin Wang, Ruili Yu, Anathbandhu Chaudhuri, Yuri Persidsky, Howard E. Gendelman and Zhiguo Rao. Their work appears in journals such as Frontiers in Oncology, PLoS ONE, Tumor Biology, Heart and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.